Lucid Diagnostics (LUCD) Current Assets (2020 - 2026)

Lucid Diagnostics' Current Assets history runs 7 years deep, the most recent figure standing at $31.4 million for Q1 2026.

• Quarterly Current Assets rose 13.89% year-over-year to $31.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.4 million (up 13.89% YoY) and the FY2025 annual result came in at $37.5 million, up 48.99% from the prior year.
• Current Assets was $31.4 million for Q1 2026 at Lucid Diagnostics, down from $37.5 million in the prior quarter.
• Across five years, Current Assets topped out at $52.3 million in Q1 2022 and bottomed at $16.8 million in Q3 2024.
• A 5-year average of $32.2 million and a median of $29.8 million in 2022 frame the typical range for Current Assets.
• Peak annual rise in Current Assets reached 1091.73% in 2022, while the deepest fall reached 57.5% in 2022.
• Lucid Diagnostics' Current Assets stood at $24.4 million in 2022, then retreated by 9.37% to $22.1 million in 2023, then grew by 13.93% to $25.1 million in 2024, then jumped by 48.99% to $37.5 million in 2025, then retreated by 16.3% to $31.4 million in 2026.
• Business Quant data shows LUCD's Current Assets at $31.4 million in Q1 2026, $37.5 million in Q4 2025, and $49.8 million in Q3 2025.